Pharmafile Logo
Pharmafocus logo
Advanced Search

Breakthrough announced in circulating tumour cell research

June 18, 2021
Medical Communications Cancer, Circulating tumour cells, Precision Medicine, oncology

Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit …

News

UK AI firm wins share of £140 million funding for lung cancer detection tech

June 18, 2021
Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology

Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …

News
astrazeneca_plaque

Australia pauses AstraZeneca vaccine for people under 60

June 18, 2021
Medical Communications AstraZeneca, Australia, COVID-19, Vaccine

Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to the rare occurrence of post-jab …

News

New class of cancer-killing drugs identified

June 18, 2021
Medical Communications Cancer, oncology

Scientists have announced the identification of a new class of cancer drugs, known as POLQ inhibitors, that specifically kill cancer …

News

NICE recommends two new treatments for inflammatory arthritis

June 18, 2021
Medical Communications Eli Lilly, NICE, Novartis

NICE has recommended two new treatments for axial spondyloarthritis, an underdiagnosed and debilitating type of inflammatory arthritis. Ixekizumab (also known …

News

Prostate cancer detection system wins government funding

June 17, 2021

A prostate cancer detection software system, to help pathologists quickly identify suspicious areas of tissue, has won government funding. The …

News

Exscientia buys Austrian cancer cell screening company for €50 million

June 17, 2021
AI, EU, deal, marketing, sales

UK-based AI pioneers Exscientia has announced the purchase of rival AI firm Allcyte for €50 million. The multimillion deal, paid …

News

NHS to pilot artificial pancreas for type 1 diabetes

June 17, 2021
NHS, diabetes, insulin, technology, wearable technology

The NHS has announced that artificial pancreases will be available to patients with type 1 diabetes, with up to 1,000 …

News

Biogen’s Phase II Alzheimer’s study misses primary endpoint

June 17, 2021

Biogen’s Phase II study for gosuranemab, an anti-tau antibody for Alzheimer’s disease, did not meet its primary endpoint, and has …

News
img_4190-e1376666350337-web

Epilepsy drug receives MHRA marketing authorisation

June 17, 2021
MHRA, epilepsy, marketing authorisation

The MHRA has granted marketing authorisation (MA) for Ontozry (cenobamate) for the treatment of focal-onset seizures in adult patients with …

News

UK COVID vaccine update

June 16, 2021
Research and Development COVID-19, UK, care homes, children, government, vaccines

Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

June 16, 2021
Research and Development

The past week has seen quite a mixed bag when it comes to COVID-19 news, an AstraZeneca antibody has failed …

News

Ground-breaking COVID antibody treatment proven to save lives

June 16, 2021
Research and Development COVID-19, UK, antibodies, trial

Results from Regeneron’s Recovery trial, investigating a potent monoclonal antibody combination treatment in hospitalised patients with severe COVID-19, have shown …

News

Signite’s sustainable decorating solution to reduce label waste by 50%

June 16, 2021
Research and Development

ACTEGA has officially launched Signite, a new decorating solution designed to significantly reduce waste in label production. The hope is …

News

Avadel’s narcolepsy Phase III trial shows positive results

June 16, 2021
Research and Development

Avadel’s Phase III trial for FT218 in patients with narcolepsy has shown positive results. The data from the trial demonstrated …

News
az

AstraZeneca antibody fails to prevent COVID in exposed patients

June 15, 2021
Manufacturing and Production AstraZeneca, COVID-19, Primary Endpoint, antibody, trial

AstraZeneca has failed to reach the primary endpoint in their Storm Chaser trial, assessing the safety and efficacy of AZD7442, …

News

Novo Holdings acquires BBI Group in £400 million deal

June 15, 2021
Manufacturing and Production acqusition, deal, finance

Novo Holdings, a holding company of the Novo Group, has acquired BBI Group from Exponent for an enterprise value of …

News

Biogen Phase III choroideremia study did not meet primary endpoint

June 15, 2021
Manufacturing and Production Biogen, choroideremia, phase III

Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …

News
integration_of_nvd-001_in_intervertebral_body_cage_fusion

Bone regeneration stem cell “putty” sees positive results in trials

June 15, 2021
Manufacturing and Production Cell regeneration, Stem cells, bone, platform, technology

Belgian clinical stage company, Novadip Biosciences, has announced positive results from its Phase I trial of its autologous cell-based osteogenic …

News

Cognito Therapeutics initiates Down syndrome Alzheimer’s study

June 15, 2021
Manufacturing and Production

Cognito Therapeutics are going to run a second digital therapeutic study evaluating individuals who have the genetic rare disease, Down …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025